Effect of Conversion from ESA with Shorter Half-Life to CERA Once Monthly for Maintaining Hb Concentration in Pre-Dialysis CKD Patients

Effect of Conversion from ESA with Shorter Half-Life to CERA Once Monthly for Maintaining Hb Concentration in Pre-Dialysis CKD Patients

Background: The purpose of this study is to identify whether hemoglobin (Hb) concentrations can be maintained, and to investigate changes in biomarkers, when switching from erythropoietin stimulating agents (ESA) with shorter half-life to once-monthly subcutaneous methoxy polyethylene glycol-epoetin...

Full description

Bibliographic Details
Main Authors: Ji-Young Choi, Chul Woo Yang, Yeong-Hoon Kim, Kwon Wook Joo, Tae-Hyun Yoo, Kang Wook Lee, Sang-Ho Lee, Ju-Young Moon, Sug Kyun Shin, Wooseong Huh, Nam-Ho Kim, Sun-Hee Park, Chan-Duck Kim, Yong-Lim Kim
Format: Article
Language:English
Published: Karger Publishers 2013-07-01
Series:Kidney & Blood Pressure Research
Subjects:
Erythropoietin
Chronic kidney disease
Biomarker
Hemoglobin
Online Access:http://www.karger.com/Article/FullText/350151

Internet

http://www.karger.com/Article/FullText/350151

Similar Items